STOCK TITAN

Olema Pharmaceuticals, Inc. (OLMA) Net Income by Year

OLMA

Olema Pharmaceuticals, Inc. reported a net loss of $162.5M in fiscal year 2025. This represents a decrease of 25.5% from the prior fiscal year. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Olema Pharmaceuticals, Inc. has filed alongside them.

FY2025 annual
Net Income -$162.5M
YoY -25.5%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

OLMA Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY25DEF 14AFY24DEF 14AFY23DEF 14AFY2210-KFY2110-KFY2010-KFY1910-K
Net Income-$162.5M-25.5%-$129.5M-34.0%-$96.7M+7.8%-$104.8M-47.4%-$71.1M-221.4%-$22.1M-412.5%-$4.3M

OLMA Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$63.2M-44.3%-$53.1M-74.7%N/A-$42.2M-22.2%-$43.8M-44.1%-$30.4M+1.9%N/A-$34.6M-60.7%-$30.4M-51.2%-$31.0M-9.5%N/A-$21.5M+5.4%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Olema Pharmaceuticals, Inc. financials

Frequently Asked Questions

What was Olema Pharmaceuticals, Inc.'s net income in fiscal year 2025?

Olema Pharmaceuticals, Inc. reported a net loss of $162.5M in fiscal year 2025.

How fast is Olema Pharmaceuticals, Inc.'s net income growing?

Olema Pharmaceuticals, Inc. (OLMA) net income fell by 25.5% year over year, from -$129.5M to -$162.5M in fiscal year 2025.

How has Olema Pharmaceuticals, Inc.'s net income changed over the years?

Across the 7 fiscal years this page covers, Olema Pharmaceuticals, Inc. (OLMA) net income went from -$4.3M in fiscal year 2019 to -$162.5M in fiscal year 2025.

Olema Pharmaceuticals, Inc. (OLMA) reported -$63.2M in net income in Q2 2026. This represents a decrease of 44.3% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Olema Pharmaceuticals, Inc. (OLMA) reported on that line in every period on record.